- Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says CNN
- FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults CNBC
- Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine Yahoo News
- FDA Flags ‘Important Potential Risk’ in Pfizer’s RSV Vaccine The Daily Beast
- RSV vaccines for babies, adults on the way. Here’s what could be coming. Chicago Sun-Times
- View Full Coverage on Google News